Inify Laboratories AB - Earnings Release 2022

Panel talk about Inify's fourth quarter 2022

From the heart of their brand-new laboratory comes this panel talk with CEO

Fredrik Palm and CTO Arto Järvinen of Inify Laboratories. Here, they discuss

progress made so far and how the Systems Engineering methodology ensures that

all components - from internal IT to equipment and logistics - fit together in

one seamless clinical workflow.

During the last quarter of 2022, Inify Laboratories moved into its brand-new

premises at Campus Solna just outside of Stockholm. The laboratory was finished

in record time and all essential milestones were reached, in terms of both

laboratory infrastructure as well as IT solutions and processes.

In this panel talk, led by Ole Eikeland, the main highlights of the quarter are

presented. Järvinen and Palm also describe how the foundation has been laid for

scalability and patient value, and provide insights into the market response so

far.

https://youtu.be/JrKmK5YARAQ

For further information, please contact CEO Fredrik Palm, [email protected]

or visit https://www.inify.com/.

Inify Laboratories is currently establishing an ultramodern laboratory that will

provide cancer diagnostics within histopathology. Designed from scratch, it uses

a fully digital, standardized and AI-supported workflow to optimize quality and

shorten response times, initially within prostate cancer. The first laboratory,

located at Campus Solna Sweden, is estimated to start offering services to both

public and private healthcare providers before summer 2023.

The company originates from ContextVision, with nearly 40 years of experience

within digital imaging for medical applications and became independent through a

spin-off in February 2022. The company, based in Sweden, is listed on Euronext

Growth Oslo under the ticker INIFY.

AI assistant